Thermo Fisher Scientific Announces Expands Sterile Filling Capacity for Therapies and Vaccines
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to develop two new sterile filling lines in Singapore to extend capacity to the Asia-Pacific region for the development and manufacture of therapies and vaccines.